| Stage | PSKY | % of rev | FOXA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.9B | 100.00% | $4.6B | 100.00% | PSKY ×1.51 |
| Gross profit | $6.9B | 100.00% | $4.6B | 100.00% | 0.0pp |
| Operating income | $475M | 6.87% | $1.5B | 32.95% | FOXA +26.1pp |
| Pre-tax income | $215M | 3.11% | $1.3B | 28.07% | FOXA +25.0pp |
| Net income | $41M | 0.59% | $957M | 20.94% | FOXA +20.3pp |
| Stage | PSKY | FOXA | Gap · A − B |
|---|---|---|---|
| Revenue | $6.9B100.00% | $4.6B100.00% | PSKY ×1.51 |
| Gross profit | 100.00%$6.9B | 100.00%$4.6B | 0.0pp |
| Operating income | 6.87%$475M | 32.95%$1.5B | FOXA +26.1pp |
| Pre-tax income | 3.11%$215M | 28.07%$1.3B | FOXA +25.0pp |
| Net income |
| 0.59%$41M |
| 20.94%$957M |
| FOXA +20.3pp |
None
No disclosed counterparties: PSKY.